Literature DB >> 8882039

Cytokines in Behçet's disease.

N Sayinalp1, O I Ozcebe, O Ozdemir, I C Haznedaroğlu, S Dündar, S Kirazli.   

Abstract

OBJECTIVE: Cytokines take place in immunologic and inflammatory reactions. The aim of this study was to describe the roles of various cytokines in the pathogenesis of Behçet's disease (BD).
METHODS: Serum levels of interleukin-1 beta (IL-1 beta), interleukin-2 (IL-2), soluble IL-2 receptor (sIL-2R), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were studied in 24 patients with active BD and 15 healthy adults as controls, by ELISA technique. Patients were separated into 2 groups according to the number of active organ systems (Group I: < 3 vs Group II: > or = 3).
RESULTS: sIL-2R and age adjusted TNF-alpha levels were higher in patients with BD compared to controls (p = 0.004 and p = 0.002, respectively). But the median concentrations of Group I and Group II were not different. Serum levels of IL-1 beta, IL-2 and IL-6 were similar to the control group.
CONCLUSION: High serum levels of sIL-2R and TNF-alpha indicate activation of the immune system in BD. But this finding may not be useful as a marker of disease activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882039

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  32 in total

1.  T-bet expression is upregulated in active Behçet's disease.

Authors:  B Li; P Yang; H Zhou; Z Zhang; C Xie; X Lin; X Huang; A Kijlstra
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Association of Higher Defensin β-4 Genomic Copy Numbers with Behçet's Disease in Iraqi Patients.

Authors:  Ammar F Hameed; Sameh Jaradat; Bassam M Al-Musawi; Khalifa Sharquie; Mazin J Ibrahim; Raafa K Hayani; Johannes Norgauer
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

3.  Serum RANTES, MIP-1alpha, and MCP-1 levels in Behçet's disease.

Authors:  Huseyin T E Ozer; Eren Erken; Ramazan Gunesacar; Oguz Kara
Journal:  Rheumatol Int       Date:  2004-11-03       Impact factor: 2.631

4.  Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis.

Authors:  Keita Fujimori; Keiko Oh-i; Masaru Takeuchi; Naoyuki Yamakawa; Takaaki Hattori; Takeshi Kezuka; Hiroshi Keino; Jun Suzuki; Hiroshi Goto; Jun-ichi Sakai; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

5.  Serum omentin, resistin and tumour necrosis factor-α levels in Behcet patients with and without ocular involvement.

Authors:  Fatih Mehmet Türkcü; Alparslan Şahin; Abdullah Kürşat Cingü; Savaş Kaya; Hatice Yüksel; Yasin Cinar; İbrahim Batmaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-23       Impact factor: 3.117

6.  Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.

Authors:  Nádia Emi Aikawa; Carla Gonçalves; Clovis Artur Almeida Silva; Célio Gonçalves; Eloísa Bonfá; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

7.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 8.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

Review 9.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  Association of TNFA promoter region haplotype in Behçet's Disease.

Authors:  KyungSook Park; NaYoung Kim; JungHyun Nam; Dongsik Bang; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.